Recruiting NCT07221643
Carotenoids in the Skin and Immune Aging
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: No Condition, Skin Carotenoids and Immune-aging. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Carotenoids in the Skin and Immune Aging: a Pilot Observational Study
Overview
This study aims to examine the connection between the level of carotenoids in the skin and a number of immune related health parameters.
Primary outcome measures
- Skin carotenoid levels and skin aging features [Time frame: one day]
Secondary outcome measures (2)
- Skin carotenoid levels and biomarkers of aging [Time frame: one day]
- Skin carotenoid levels and self-reported perception of health [Time frame: 2 weeks]
Eligibility criteria
Inclusion criteria
- Willing and able to provide written informed consent
- Age 18-30 years OR 65 years and older
- Healthy individuals without uncontrolled medical conditions (over the counter inhaled and topical steroids allowed)
- Fiitzpatrick I-VI (all skin types)
Exclusion criteria
- Pregnant or breastfeeding
- uncontrolled medical conditions
- Skin conditions on the upper extremity that would interfere with skin measurements of carotenoid levels such as active atopic dermatitis or psoriasis
- Concurrent use of medications that affect the immune system, within 4 weeks of enrollment (eg. prednisone, biologics, methotrexate, rapamycin, prescription topical steroids, prescription inhaled steroids, others)
- Unable to follow study protocol
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Stanford Health - General Dermatology Clinic — Redwood City
Identifiers
NCT: NCT07221643 · 80982